{"count": 16, "results": [{"_id": "32490289", "pmid": 32490289, "pmcid": "PMC7260677", "title": "Metformin protects from oxaliplatin induced peripheral neuropathy in rats", "journal": "Neurobiol Pain", "authors": ["Martinez NW", "Sánchez A", "Diaz P", "Broekhuizen R", "Godoy J", "Mondaca S", "Catenaccio A", "Macanas P", "Nervi B", "Calvo M", "Court FA"], "date": "2020-05-22T00:00:00Z", "doi": "10.1016/j.ynpai.2020.100048", "meta_date_publication": "2020 Aug-Dec", "meta_volume": "8", "meta_issue": "", "meta_pages": "100048", "score": 50260.41, "text_hl": "The concomitant use of @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ prevented degeneration of intraepidermal fibers, @<m>DISEASE_Gliosis</m> @DISEASE_MESH:D005911 @@@gliosis@@@, and the altered sensitivity. ", "citations": {"NLM": "Martinez NW, Sánchez A, Diaz P, Broekhuizen R, Godoy J, Mondaca S, Catenaccio A, Macanas P, Nervi B, Calvo M, Court FA. Metformin protects from oxaliplatin induced peripheral neuropathy in rats Neurobiol Pain. 2020 Aug-Dec;8():100048. PMID: 32490289", "BibTeX": "@article{32490289, title={Metformin protects from oxaliplatin induced peripheral neuropathy in rats}, author={Martinez NW and Sánchez A and Diaz P and Broekhuizen R and Godoy J and Mondaca S and Catenaccio A and Macanas P and Nervi B and Calvo M and Court FA}, journal={Neurobiol Pain}, volume={8}, pages={100048}}"}}, {"_id": "36303102", "pmid": 36303102, "title": "Early Treatment with Metformin Improves Neurological Outcomes in Lafora Disease.", "journal": "Neurotherapeutics", "authors": ["Burgos DF", "Machío-Castello M", "Iglesias-Cabeza N", "Giráldez BG", "González-Fernández J", "Sánchez-Martín G", "Sánchez MP", "Serratosa JM"], "date": "2022-10-27T00:00:00Z", "doi": "10.1007/s13311-022-01304-w", "meta_date_publication": "2022 Oct 27", "meta_volume": "", "meta_issue": "", "meta_pages": "", "score": 50258.066, "text_hl": "We also analyzed the effects on @DISEASE_Lafora_Disease @DISEASE_MESH:D020192 @@@Lafora bodies@@@, @DISEASE_Neurodegenerative_Diseases @DISEASE_MESH:D019636 @@@neurodegeneration@@@, and @<m>DISEASE_Gliosis</m> @DISEASE_MESH:D005911 @@@astrogliosis@@@. Furthermore, we conducted a follow-up study of an initial cohort of 18 @SPECIES_9606 @@@patients@@@ with @DISEASE_Lafora_Disease @DISEASE_MESH:D020192 @@@Lafora disease@@@, 8 treated with @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ and 10 untreated. ", "citations": {"NLM": "Burgos DF, Machío-Castello M, Iglesias-Cabeza N, Giráldez BG, González-Fernández J, Sánchez-Martín G, Sánchez MP, Serratosa JM. Early Treatment with Metformin Improves Neurological Outcomes in Lafora Disease. Neurotherapeutics. 2022 Oct 27;():. PMID: 36303102", "BibTeX": "@article{36303102, title={Early Treatment with Metformin Improves Neurological Outcomes in Lafora Disease.}, author={Burgos DF and Machío-Castello M and Iglesias-Cabeza N and Giráldez BG and González-Fernández J and Sánchez-Martín G and Sánchez MP and Serratosa JM}, journal={Neurotherapeutics}}"}}, {"_id": "34903525", "pmid": 34903525, "pmcid": "PMC8805198", "title": "Metformin Reduces Repeat Mild Concussive Injury Pathophysiology", "journal": "eNeuro", "authors": ["Underwood EL", "Redell JB", "Maynard ME", "Kobori N", "Hylin MJ", "Hood KN", "West RK", "Zhao J", "Moore AN", "Dash PK"], "date": "2022-01-13T00:00:00Z", "doi": "10.1523/ENEURO.0421-21.2021", "meta_date_publication": "2022 Jan-Feb", "meta_volume": "9", "meta_issue": "1", "meta_pages": "", "score": 50256.0, "text_hl": "Acute @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ treatment attenuated @DISEASE_Fractures_Spontaneous @DISEASE_MESH:D005598 @@@axonal pathologies@@@, @<m>DISEASE_Gliosis</m> @DISEASE_MESH:D005911 @@@astrogliosis@@@, elements of mitochondrial function, motor, and @DISEASE_Cognition_Disorders @DISEASE_MESH:D003072 @@@cognitive deficits@@@. ", "citations": {"NLM": "Underwood EL, Redell JB, Maynard ME, Kobori N, Hylin MJ, Hood KN, West RK, Zhao J, Moore AN, Dash PK. Metformin Reduces Repeat Mild Concussive Injury Pathophysiology eNeuro. 2022 Jan-Feb;9(1):. PMID: 34903525", "BibTeX": "@article{34903525, title={Metformin Reduces Repeat Mild Concussive Injury Pathophysiology}, author={Underwood EL and Redell JB and Maynard ME and Kobori N and Hylin MJ and Hood KN and West RK and Zhao J and Moore AN and Dash PK}, journal={eNeuro}, volume={9}, number={1}}"}}, {"_id": "32679167", "pmid": 32679167, "title": "The possible role of progranulin on anti-inflammatory effects of metformin in temporal lobe epilepsy.", "journal": "J Chem Neuroanat", "authors": ["Vazifehkhah S", "Khanizadeh AM", "Mojarad TB", "Nikbakht F"], "date": "2020-11-01T00:00:00Z", "doi": "10.1016/j.jchemneu.2020.101849", "meta_date_publication": "2020 Nov", "meta_volume": "109", "meta_issue": "", "meta_pages": "101849", "score": 50255.207, "text_hl": "In sum, we have concluded that @GENE_GRN @GENE_29143 @@@progranulin@@@ can be a key mediator in @DISEASE_Epilepsy @DISEASE_MESH:D004827 @@@epilepsy@@@, and the anti-@DISEASE_Inflammation @DISEASE_MESH:D007249 @@@inflammatory@@@ action of @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ in @DISEASE_Status_Epilepticus @DISEASE_MESH:D013226 @@@status epilepticus@@@ is through increasing the secretion of @GENE_IL10 @GENE_25325 @@@IL-10@@@ and inhibiting @GENE_IL1B @GENE_24494 @@@IL-1 beta@@@ and @<m>DISEASE_Gliosis</m> @DISEASE_MESH:D005911 @@@astrogliosis@@@.", "citations": {"NLM": "Vazifehkhah S, Khanizadeh AM, Mojarad TB, Nikbakht F. The possible role of progranulin on anti-inflammatory effects of metformin in temporal lobe epilepsy. J Chem Neuroanat. 2020 Nov;109():101849. PMID: 32679167", "BibTeX": "@article{32679167, title={The possible role of progranulin on anti-inflammatory effects of metformin in temporal lobe epilepsy.}, author={Vazifehkhah S and Khanizadeh AM and Mojarad TB and Nikbakht F}, journal={J Chem Neuroanat}, volume={109}, pages={101849}}"}}, {"_id": "36439719", "pmid": 36439719, "pmcid": "PMC9681650", "title": "Regulation of the apoptosis/autophagy switch by propionic acid in ventromedial hypothalamus of rats with type 2 diabetes mellitus", "journal": "Heliyon", "authors": ["Natrus L", "Osadchuk Y", "Lisakovska O", "Roch T", "Babel N", "Klys Y", "Labudzynskyi D", "Chaikovsky Y"], "date": "2022-11-14T00:00:00Z", "doi": "10.1016/j.heliyon.2022.e11529", "meta_date_publication": "2022 Nov", "meta_volume": "8", "meta_issue": "11", "meta_pages": "e11529", "score": 50250.957, "text_hl": "@<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@ inhibited @DISEASE_Malformations_of_Cortical_Development_Group_I @DISEASE_MESH:D065703 @@@neuronal apoptosis@@@, however, caused reactive @<m>DISEASE_Gliosis</m> @DISEASE_MESH:D005911 @@@astrogliosis@@@ and accumulation of @CHEMICAL_Lipofuscin @CHEMICAL_MESH:D008062 @@@lipofuscin@@@ granules. ", "citations": {"NLM": "Natrus L, Osadchuk Y, Lisakovska O, Roch T, Babel N, Klys Y, Labudzynskyi D, Chaikovsky Y. Regulation of the apoptosis/autophagy switch by propionic acid in ventromedial hypothalamus of rats with type 2 diabetes mellitus Heliyon. 2022 Nov;8(11):e11529. PMID: 36439719", "BibTeX": "@article{36439719, title={Regulation of the apoptosis/autophagy switch by propionic acid in ventromedial hypothalamus of rats with type 2 diabetes mellitus}, author={Natrus L and Osadchuk Y and Lisakovska O and Roch T and Babel N and Klys Y and Labudzynskyi D and Chaikovsky Y}, journal={Heliyon}, volume={8}, number={11}, pages={e11529}}"}}, {"_id": "34570348", "pmid": 34570348, "title": "Metformin Therapy Attenuates Pro-inflammatory Microglia by Inhibiting NF-kappaB in Cuprizone Demyelinating Mouse Model of Multiple Sclerosis.", "journal": "Neurotox Res", "authors": ["Abdi M", "Pasbakhsh P", "Shabani M", "Nekoonam S", "Sadeghi A", "Fathi F", "Abouzaripour M", "Mohamed W", "Zibara K", "Kashani IR", "Zendedel A"], "date": "2021-12-01T00:00:00Z", "doi": "10.1007/s12640-021-00417-y", "meta_date_publication": "2021 Dec", "meta_volume": "39", "meta_issue": "6", "meta_pages": "1732-1746", "score": 50249.49, "text_hl": "In addition, @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ therapy significantly alleviated reactive microgliosis and @<m>DISEASE_Gliosis</m> @DISEASE_MESH:D005911 @@@astrogliosis@@@ in the corpus callosum, as measured by @GENE_IBA1 @GENE_114737 @@@Iba-1@@@ and @GENE_GFAP @GENE_14580 @@@GFAP@@@ staining. ", "citations": {"NLM": "Abdi M, Pasbakhsh P, Shabani M, Nekoonam S, Sadeghi A, Fathi F, Abouzaripour M, Mohamed W, Zibara K, Kashani IR, Zendedel A. Metformin Therapy Attenuates Pro-inflammatory Microglia by Inhibiting NF-kappaB in Cuprizone Demyelinating Mouse Model of Multiple Sclerosis. Neurotox Res. 2021 Dec;39(6):1732-1746. PMID: 34570348", "BibTeX": "@article{34570348, title={Metformin Therapy Attenuates Pro-inflammatory Microglia by Inhibiting NF-kappaB in Cuprizone Demyelinating Mouse Model of Multiple Sclerosis.}, author={Abdi M and Pasbakhsh P and Shabani M and Nekoonam S and Sadeghi A and Fathi F and Abouzaripour M and Mohamed W and Zibara K and Kashani IR and Zendedel A}, journal={Neurotox Res}, volume={39}, number={6}, pages={1732-1746}}"}}, {"_id": "33818507", "pmid": 33818507, "pmcid": "PMC8354108", "title": "Low-dose metformin treatment in the subacute phase improves the locomotor function of a mouse model of spinal cord injury", "journal": "Neural Regen Res", "authors": ["Song WY", "Ding H", "Dunn T", "Gao JL", "Labastida JA", "Schlagal C", "Ning GZ", "Feng SQ", "Wu P"], "date": "2021-11-01T00:00:00Z", "doi": "10.4103/1673-5374.310695", "meta_date_publication": "2021 Nov", "meta_volume": "16", "meta_issue": "11", "meta_pages": "2234-2242", "score": 50246.887, "text_hl": "The current study demonstrated that @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@, administrated at a dose of 100 mg/kg starting at the subacute phase after injury, significantly improved the locomotor function in @SPECIES_10090 @@@mice@@@ and inhibited the activation of microglia/macrophage and @<m>DISEASE_Gliosis</m> @DISEASE_MESH:D005911 @@@astrogliosis@@@ at the lesion site. ", "citations": {"NLM": "Song WY, Ding H, Dunn T, Gao JL, Labastida JA, Schlagal C, Ning GZ, Feng SQ, Wu P. Low-dose metformin treatment in the subacute phase improves the locomotor function of a mouse model of spinal cord injury Neural Regen Res. 2021 Nov;16(11):2234-2242. PMID: 33818507", "BibTeX": "@article{33818507, title={Low-dose metformin treatment in the subacute phase improves the locomotor function of a mouse model of spinal cord injury}, author={Song WY and Ding H and Dunn T and Gao JL and Labastida JA and Schlagal C and Ning GZ and Feng SQ and Wu P}, journal={Neural Regen Res}, volume={16}, number={11}, pages={2234-2242}}"}}, {"_id": "32580040", "pmid": 32580040, "title": "Neuroprotective potential of antihyperglycemic drug metformin in streptozocin-induced rat model of sporadic Alzheimer's disease.", "journal": "Eur J Pharmacol", "authors": ["Pilipenko V", "Narbute K", "Pupure J", "Langrate IK", "Muceniece R", "Kluša V"], "date": "2020-08-15T00:00:00Z", "doi": "10.1016/j.ejphar.2020.173290", "meta_date_publication": "2020 Aug 15", "meta_volume": "881", "meta_issue": "", "meta_pages": "173290", "score": 50246.535, "text_hl": "Microgliosis and @<m>DISEASE_Gliosis</m> @DISEASE_MESH:D005911 @@@astrogliosis@@@ were ameliorated by @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ in @DISEASE_Alzheimer_Disease @DISEASE_MESH:D000544 @@@sAD@@@ model @SPECIES_10116 @@@rats@@@. ", "citations": {"NLM": "Pilipenko V, Narbute K, Pupure J, Langrate IK, Muceniece R, Kluša V. Neuroprotective potential of antihyperglycemic drug metformin in streptozocin-induced rat model of sporadic Alzheimer's disease. Eur J Pharmacol. 2020 Aug 15;881():173290. PMID: 32580040", "BibTeX": "@article{32580040, title={Neuroprotective potential of antihyperglycemic drug metformin in streptozocin-induced rat model of sporadic Alzheimer's disease.}, author={Pilipenko V and Narbute K and Pupure J and Langrate IK and Muceniece R and Kluša V}, journal={Eur J Pharmacol}, volume={881}, pages={173290}}"}}, {"_id": "39775196", "pmid": 39775196, "title": "Aerobic exercise and metformin attenuate the cognitive impairment in an experimental model of type 2 diabetes mellitus: focus on neuroinflammation and adult hippocampal neurogenesis.", "journal": "Metab Brain Dis", "authors": ["Padhy DS", "Aggarwal P", "Velayutham R", "Banerjee S"], "date": "2025-01-07T00:00:00Z", "doi": "10.1007/s11011-024-01489-3", "meta_date_publication": "2025 Jan 7", "meta_volume": "40", "meta_issue": "1", "meta_pages": "92", "score": 50243.4, "text_hl": "The level of @DISEASE_Neuroinflammatory_Diseases @DISEASE_MESH:D000090862 @@@neuroinflammation@@@ was significantly elevated in the hippocampal tissue of @DISEASE_Diabetes_Mellitus_Type_2 @DISEASE_MESH:D003924 @@@T2DM@@@ @SPECIES_10116 @@@rats@@@ compared to the control and lowered after exercise and @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ treatment. @DISEASE_Diabetes_Mellitus_Type_2 @DISEASE_MESH:D003924 @@@T2DM@@@ reduced mature neurons and neurogenesis while increasing @<m>DISEASE_Gliosis</m> @DISEASE_MESH:D005911 @@@astrogliosis@@@ and microgliosis, ameliorated by exercise and @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ treatment. ", "citations": {"NLM": "Padhy DS, Aggarwal P, Velayutham R, Banerjee S. Aerobic exercise and metformin attenuate the cognitive impairment in an experimental model of type 2 diabetes mellitus: focus on neuroinflammation and adult hippocampal neurogenesis. Metab Brain Dis. 2025 Jan 7;40(1):92. PMID: 39775196", "BibTeX": "@article{39775196, title={Aerobic exercise and metformin attenuate the cognitive impairment in an experimental model of type 2 diabetes mellitus: focus on neuroinflammation and adult hippocampal neurogenesis.}, author={Padhy DS and Aggarwal P and Velayutham R and Banerjee S}, journal={Metab Brain Dis}, volume={40}, number={1}, pages={92}}"}}, {"_id": "27566243", "pmid": 27566243, "title": "Effect of canagliflozin and metformin on cortical neurotransmitters in a diabetic rat model.", "journal": "Chem Biol Interact", "authors": ["Arafa NM", "Marie MA", "AlAzimi SA"], "date": "2016-10-25T00:00:00Z", "doi": "10.1016/j.cbi.2016.08.016", "meta_date_publication": "2016 Oct 25", "meta_volume": "258", "meta_issue": "", "meta_pages": "79-88", "score": 50057.06, "text_hl": "Focal @<m>DISEASE_Gliosis</m> @DISEASE_MESH:D005911 @@@gliosis@@@ in the cerebrum of @SPECIES_10116 @@@rats@@@ in the @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@MET@@@-treated group was observed after 2 and 4 weeks of treatment. ", "citations": {"NLM": "Arafa NM, Marie MA, AlAzimi SA. Effect of canagliflozin and metformin on cortical neurotransmitters in a diabetic rat model. Chem Biol Interact. 2016 Oct 25;258():79-88. PMID: 27566243", "BibTeX": "@article{27566243, title={Effect of canagliflozin and metformin on cortical neurotransmitters in a diabetic rat model.}, author={Arafa NM and Marie MA and AlAzimi SA}, journal={Chem Biol Interact}, volume={258}, pages={79-88}}"}}]}